Publikationen von B. Müller-Myhsok

Horstmann, S.; Lucae, S.; Menke, A.; Ising, M.; Müller-Myhsok, B.; Holsboer, F.; Binder, E.: Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients. European Neuropsychopharmacology 18 (Suppl. 4), S. S214 - S215 (2008)

Kloiber, S.; Kohli, M. A.; Brueckl, T.; Ising, M.; Uhr, M.; Menke, A.; Müller-Myhsok, B.; Holsboer, F.; Lucae, S.: Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression. European Neuropsychopharmacology 18 (Suppl. 4), S. S296 - S296 (2008)

Schormair, B.; Kemlink, D.; Roeske, D.; Eckstein, G.; Xiong, L.; Lichtner, P.; Ripke, S.; Trenkwalder, C.; Zimprich, A.; Stiasny-Kolster, K. et al.; Oertel, W.; Bachmann, C. G.; Paulus, W.; Högl, B.; Frauscher, B.; Gschliesser, V.; Poewe, W.; Peglau, I.; Vodicka, P.; Vavrova, J.; Sonka, K.; Nevsimalova, S.; Montplaisir, J.; Turecki, G.; Rouleau, G.; Gieger, C.; Illig, T.; Wichmann, H. E.; Holsboer, F.; Mueller-Myhsok, B.; Meitinger, T.; Winkelmann, J.: PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nature Genetics 40 (8), S. 946 - 948 (2008)

Horstmann, S.; Lucae, S.; Menke, A.; Kohli, M.; Bettecken, T.; Uhr, M.; Ripke, S.; Ising, M.; Müller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.: Association of GRIK4 and 5-HTR2A with antidepressant treatment in the MARS cohort of depressed impatients. International Journal of Neuropsychopharmacology 11 (Suppl. 1), S. 112 - 113 (2008)

Ising, M.; Silja, A.; Lucae, S.; Siebertz, A.; Depping, A. M.; Modell, S.; Müller-Myhsok, B.; Holsboer, F.: Molecular genetics of individual differences: What can we learn for related disorders? International Journal of Psychology 43 (3-4), S. 195 - 195 (2008)

Schumacher, J.; König, I. R.; Schröder, T.; Duell, M.; Plume, E.; Propping, P.; Warnke, A.; Libertus, C.; Ziegler, A.; Müller-Myhsok, B. et al.; Schulte-Korne, G.; Nöthen, M. M.: Further evidence for a susceptibility locus contributing to reading disability on chromosome 15q15-q21. Psychiatric Genetics 18 (3), S. 137 - 142 (2008)

Weber, F.; Fontaine, B.; Cournu-Rebeix, I.; Kroner, A.; Knop, M.; Lutz, S.; Müller-Sarnowski, F.; Uhr, M.; Bettecken, T.; Kohli, M. et al.; Ripke, S.; Ising, M.; Rieckmann, P.; Brassat, D.; Semana, G.; Babron, M. C.; Mrejen, S.; Gout, C.; Lyon-Caen, O.; Yaouanq, J.; Edan, G.; Clanet, M.; Holsboer, F.; Clerget-Darpoux, F.; Müller-Myhsok, B.: IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Journal of Neurology 255 (Suppl. 2), S. 52 - 53 (2008)

Kemlink, D.; Plazzi, G.; Vetrugno, R.; Provini, F.; Polo, O.; Stiasny-Kolster, K.; Oertel, W.; Nevsimalova, S.; Sonka, K.; Högl, B. et al.; Frauscher, B.; Hadjigeorgiou, G. M.; Pramstaller, P. P.; Lichtner, P.; Meitinger, T.; Müller-Myhsok, B.; Winkelmann, J.; Montagna, P.: Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics 9 (2), S. 75 - 82 (2008)

Freilinger, T.; Bohe, M.; Wegener, B.; Müller-Myhsok, B.; Dichgans, M.; Knoblauch, H.: Expansion of the phenotypic spectrum of the CACNA1A T666M mutation: a family with familial hemiplegic migraine type 1, cerebellar atrophy and mental retardation. Cephalalgia 28 (4), S. 403 - 407 (2008)

Ising, M.; Adena, S.; Binder, E.; Pfennig, A.; Schalling, M.; Mueller-Myhsok, B.; Modell, S.; Holsboer, F.: Genetic determinants of neurobiological vulnerability markers in depression. European Psychiatry 23 (Suppl. 2), S. S9 - S9 (2008)

Menke, A.; Lucae, S.; Kloiber, S.; Horstmann, S.; Bettecken, T.; Uhr, M.; Ripke, S.; Ising, M.; Müller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.: Polymorphisms in metabotropic glutamate receptor 1 are associated with major depressive disorder. Biological Psychiatry 63 (7 Suppl. S), S. 83S - 84S (2008)

Seiderer, J.; Dambacher, J.; Leistner, D.; Tillack, C.; Glas, J.; Niess, J. H.; Pfennig, S.; Jürgens, M.; Müller-Myhsok, B.; Göke, B. et al.; Ochsenkühn, T.; Lohse, P.; Reinecker, H. C.; Brand, S.: Genotype-phenotype analysis of the CXCL 16 p.Ala181Val polymorphism in inflammatory bowel disease. Clinical Immunology 127 (1), S. 49 - 55 (2008)

Seiderer, J.; Elben, I.; Diegelmann, J.; Glas, J.; Stallhofer, J.; Tillack, C.; Pfennig, S.; Jürgens, M.; Schmechel, S.; Konrad, A. et al.; Göke, B.; Ochsenkühn, T.; Müller-Myhsok, B.; Lohse, P.; Brand, S.: Role of the novel th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.Hisl6lArg polymorphism in IBD. Inflammatory Bowel Diseases 14 (4), S. 437 - 445 (2008)

Weber, F.; Fontaine, B.; Cournu-Rebeix, I.; Kroner, A.; Knop, M.; Lutz, S.; Müller-Sarnowski, F.; Uhr, M.; Bettecken, T.; Kohli, M. et al.; Ripke, S.; Ising, M.; Rieckmann, P.; Brassat, D.; Semana, G.; Babron, M. C.; Mrejen, S.; Gout, C.; Lyon-Caen, O.; Yaouanq, J.; Edan, G.; Clanet, M.; Holsboer, F.; Clerget-Darpoux, F.; Müller-Myhsok, B.: IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes and Immunity 9 (3), S. 259 - 263 (2008)

Erhardt, A.; Lucae, S.; Kern, N.; Unschuld, P. G.; Ising, M.; Lieb, R.; Uhr, M.; Hohoff, C.; Deckert, J.; Bandelow, B. et al.; Maier, W.; Binder, E. B.; Müller-Myhsok, B.; Keck, M. E.; Holsboer, F.: Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks. Molecular Psychiatry 13 (3), S. 242 - 243 (2008)

Glas, J.; Konrad, A.; Schmechel, S.; Dambacher, J.; Seiderer, J.; Schroff, F.; Wetzke, M.; Roeske, D.; Torok, H. P.; Tonenchi, L. et al.; Pfennig, S.; Haller, D.; Griga, T.; Klein, W.; Epplen, J. T.; Folwaczny, C.; Lohse, P.; Göke, B.; Ochsenkühn, T.; Mussack, T.; Folwaczny, M.; Müller-Myhsok, B.; Brand, S.: The ATG16L1 Gene Variants rs2241879 and rs2241880 (T300A) Are Strongly Associated With Susceptibility to Crohn's Disease in the German Population. American Journal of Gastroenterology 103 (3), S. 682 - 691 (2008)

Menke, A.; Lucae, S.; Kloiber, S.; Horstmann, S.; Uhr, M.; Pütz, B.; Ripke, S.; Müller-Myhsok, B.: Glutamate and interleukin receptor genes are associated with antidepressant treatment emergent suicidal ideation. European Neuropsychopharmacology 18 (Suppl. 1), S. S70 - S71 (2008)

Winkelmann, J.; Müller-Myhsok, B.: Genetics of restless legs syndrome - A burning urge to move. Neurology 70 (9), S. 664 - 665 (2008)

Winkelmann, J.; Lichtner, P.; Schormair, B.; Uhr, M.; Hauk, S.; Stiasny-Kolster, K.; Trenkwalder, C.; Paulus, W.; Peclau, I.; Eisensehr, I. et al.; Illig, T.; Wichmann, H. E.; Pfister, H.; Golic, J.; Bettecken, T.; Pütz, B.; Holsboer, F.; Meitinger, T.; Müller-Myhsok, B.: Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Movement Disorders 23 (3), S. 350 - 358 (2008)

Browning, B. L.; Annese, V.; Barclay, M. L.; Bingham, S. A.; Brand, S.; Buning, C.; Castro, M.; Cucchiara, S.; Dallapiccola, B.; Drummond, H. et al.; Ferguson, L. R.; Ferraris, A.; Fisher, S. A.; Gearry, R. B.; Glas, J.; Henckaerts, L.; Huebner, C.; Knafelz, D.; Lakatos, L.; Lakatos, P. L.; Latiano, A.; Liu, X.; Mathew, C.; Müller-Myhsok, B.; Newman, W. G.; Nimmo, E. R.; Noble, C. L.; Palmieri, O.; Parkes, M.; Petermann, I.; Rutgeerts, P.; Satsangi, J.; Shelling, A. N.; Siminovitch, K. A.; Torok, H. P.; Tremelling, M.; Vermeire, S.; Valvano, M. R.; Witt, H.: Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. Journal of Medical Genetics 45 (1), S. 36 - 42 (2008)